E-LIB Suche - Ergebnisse für: Loeser, Anne L.

1

The patient perspective on dose optimization for anticancer..:

Maués, Julia ; Loeser, Anne ; Cowden, Janice...
Clinical Trials. 21 (2024) 3 - p. 358-362 , 2024

Link: https://doi.org/10.1177/..

2

Patient-centered dosing: oncologists' perspectives about tr..:

Loeser, Anne L. ; Gao, Lucy ; Bardia, Aditya...
Breast Cancer Research and Treatment. 196 (2022) 3 - p. 549-563 , 2022

Link: https://doi.org/10.1007/..

3

Stimmen - Körper - Medien

, In: Handbuch des Gesangs / herausgegeben von Thomas Seedorf
Band 2,

Gesang im 20. und 21. Jahrhundert

Grosch, Nils ; Seedorf, Thomas ; Grotjahn, Rebecca... , [2021]

Exemplar: Zentrale:KV mus

4

DRESS SYNDROME: TREATMENT OF ORAL LESIONS WITH LASERTHERAPY:

MOURA, ANNE EVELYN OLIVEIRA ; ANDRADE, RAYLE MONTEIRO ; LOESER, JULYANI MOTA SOUZA...
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 130 (2020) 3 - p. e221 , 2020

Link: https://doi.org/10.1016/..

5

Dickkopf-2 (DKK2) as Context Dependent Factor in Patients w..:

Schiffmann, Lars M. ; Loeser, Heike ; Jacob, Anne Sophie...
Cancers. 12 (2020) 2 - p. 451 , 2020

Link: https://doi.org/10.3390/..

6

Dickkopf-2 (DKK2) as Context Dependent Factor in Patients w..:

Lars M. Schiffmann ; Heike Loeser ; Anne Sophie Jacob...
https://dx.doi.org/10.3390/cancers12020451. , 2020

Link: https://doi.org/10.3390/..

7

A consensus-based framework for conducting and reporting os..:

Spil, W.E. (Willem) van ; Bierma-Zeinstra, S.M. (Sita) ; Deveza, L.A. (L. A.)...
http://repub.eur.nl/pub/125780. , 2020

Link: http://repub.eur.nl/pub/..

8

Dickkopf-2 (DKK2) as Context Dependent Factor in Patients w..:

Schiffmann, Lars M ; Loeser, Heike ; Jacob, Anne Sophie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072714/. , 2020

Link: http://www.ncbi.nlm.nih...

9

Dickkopf-2 (DKK2) as Context Dependent Factor in Patients w..:

Lars M. Schiffmann ; Heike Loeser ; Anne Sophie Jacob...
https://www.mdpi.com/2072-6694/12/2/451. , 2020

Link: https://doi.org/10.3390/..

10

The OMERACT-OARSI Core Domain Set for Measurement in Clinic..:

Smith, Toby O ; Hawker, Gillian A ; Hunter, David J...
Smith , T O , Hawker , G A , Hunter , D J , March , L M , Boers , M , Shea , B J , Christensen , R , Guillemin , F , Terwee , C B , Williamson , P R , Dodd , S , Roos , E M , Loeser , R F , Schnitzer , T J , Kloppenburg , M , Neogi , T , Ladel , C H , Kalsi , G , Kaiser , U , Buttel , T W , Ashford , A E , Mobasheri , A , Arden , N K , Tennant , A , Hochberg , M C , de Wit , M , Tugwell , P & Conaghan , P G 2019 , ' The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis ' , Journal of Rheumatology , vol. 46 , no. 8 , 181194 , pp. 981-989 . https://doi.org/10.3899/jrheum.181194. , 2019

Link: https://portal.findresea..

11

Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Cor..:

Smith, Toby O ; Mansfield, Michael ; Hawker, Gillian A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10794886/. , 2019

Link: http://www.ncbi.nlm.nih...

12

The OMERACT-OARSI Core Domain Set for Measurement in Clinic..:

Smith, Toby O ; Hawker, Gillian A ; Hunter, David J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10753652/. , 2019

Link: http://www.ncbi.nlm.nih...

13

Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Cor..:

Smith, Toby O ; Mansfield, Michael ; Hawker, Gillian A...
Smith , T O , Mansfield , M , Hawker , G A , Hunter , D J , March , L M , Boers , M , Shea , B J , Christensen , R , Guillemin , F , Terwee , C B , Williamson , P R , Roos , E M , Loeser , R F , Schnitzer , T J , Kloppenburg , M , Neogi , T , Ladel , C H , Kalsi , G , Kaiser , U , Buttel , T W , Ashford , A E , Mobasheri , A , Arden , N K , Tennant , A , Hochberg , M C , de Wit , M , Tugwell , P & Conaghan , P G 2019 , ' Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set : Review of Randomized Controlled Trials from 1997 to 2017 ' , Journal of Rheumatology , vol. 46 , no. 8 , 181066 , pp. 976-980 . https://doi.org/10.3899/jrheum.181066. , 2019

Link: https://portal.findresea..

14

Expression of p16INK4a is a biomarker of chondrocyte aging ..:

Diekman, Brian O. ; Sessions, Garrett A. ; Collins, John A....
Aging Cell. 17 (2018) 4 - p. , 2018

Link: https://doi.org/10.1111/..

15

Expression of p16INK 4a is a biomarker of chondrocyte aging..:

Diekman, Brian O ; Sessions, Garrett A ; Collins, John A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052464/. , 2018

Link: http://www.ncbi.nlm.nih...